Related Experiment Video
Updated: Mar 16, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
AUDIT OF PARACETAMOL PRESCRIPTIONS IN PAEDIATRIC SURGICAL PATIENTS
Rowena McArtney1, Angharad Atkinson1
1Cardiff and Vale UHB.
Insights
This audit found poor adherence to guidelines for prescribing paracetamol (acetaminophen) to overweight and obese children, risking overdosing. Updated guidelines now recommend dosing based on lean body mass and reduced maximum daily doses.
Area of Science:
- Pediatric Surgery
- Pharmacology
- Clinical Audit
Background:
- Local guidelines (2012) recommended ideal body weight (IBW) for paracetamol dosing in overweight/obese children to prevent overdosing.
- Overweight and obese children are at increased risk of paracetamol toxicity if doses are based on actual body weight.
- BNF for Children (BNFC) indicates severe toxicity with doses as low as 75 mg/kg/24h.
Purpose of the Study:
- To audit compliance with local guidelines for peri-operative paracetamol dosing in pediatric surgical patients.
- To assess the accuracy of paracetamol dosing in overweight and obese children.
- To identify potential risks of inadvertent overdosing and prolonged IV use.
Main Methods:
- An audit of 100 inpatient and 35 discharge paracetamol prescriptions for pediatric surgical patients over 10 weeks.
- Patients were classified as overweight or obese using UK growth charts.
- Prescriptions were analyzed for weight documentation, dosing based on IBW, route of administration, and IV to oral switch compliance.
Main Results:
- Weight documented for 84% inpatient, 94% discharge prescriptions; height was not documented.
- Doses for overweight/obese patients ranged from 13-33 mg/kg/dose, with some exceeding recommended IBW calculations.
- 20 of 52 patients on IV paracetamol were not reviewed at 48 hours for oral switch, with only 3 appropriate prolonged IV prescriptions.
Conclusions:
- Inadequate compliance with prescribing guidelines poses a risk of inappropriate paracetamol dosing in overweight and obese children.
- Unnecessarily prolonged IV paracetamol use was observed.
- Local guidelines were updated in 2015 to reflect lean body mass dosing and a reduced maximum daily dose (75 mg/kg/day); prescriber education is needed.
Aim:
Local Guidelines for peri-operative pain management in children published in 2012 recommended that paracetamol dosing was calculated using ideal body weight (IBW) to prevent inadvertent overdosing in overweight and obese children.1 The purpose of this audit was to establish compliance with these guidelines. The oral paracetamol dose recommended was 20-30 mg/kg as a single dose then 15-20 mg/kg every 4-6 hrs with a maximum of 90 mg/kg/day. IV paracetamol doses were as recommended in BNF for Children (BNFC).2 BNFC states that paracetamol doses totalling 150 mg/kg may cause severe hepatocellular necrosis and renal tubular necrosis but the potential for adverse effects in some children can be seen with doses as little as 75 mg/kg in 24 hrs.
Method:
Paediatric Surgical patients prescribed paracetamol as an inpatient or on discharge over a 10 week period were included in the audit. For this audit patients were assessed as overweight or obese using age and gender specific UK growth charts endorsed by the Department of Health.
Audit Standards:
100% compliance with the following:1. inpatient charts and discharge prescriptions document patient weight and height.2. paracetamol prescriptions based on ideal weight for height in overweight and obese paediatric patients.3. prescriptions have IV route prescribed independently to oral (PO) or rectal route.4. patients prescribed IV paracetamol reviewed after 48 hrs for an oral switch.
Results:
100 inpatient prescriptions (71 elective and 29 non-elective) and 35 discharge prescriptions were analysed.1. Weight was annotated for 84% of inpatient prescriptions and 94% of discharge prescriptions; height was not documented for any patient. Therefore data was analysed basing IBW on 50th centile of the UK growth charts.2. The following results are based on IBW: ▸ Six inpatients prescribed oral paracetamol were classified as overweight or obese; doses ranged from 17.4-30 mg/kg/dose. ▸ Four patients prescribed IV paracetamol were classified as overweight or obese; doses ranged from 20-23 mg/kg/dose. ▸ Four patients prescribed the combined route of PO/IV paracetamol were classified as overweight or obese; doses ranged from 18-24 mg/kg/dose. ▸ Six patients prescribed oral paracetamol on discharge were classified as overweight or obese; doses ranged from 13-33 mg/kg/dose.3. Paracetamol was prescribed as IV/PO in 32 inpatients.4. IV paracetamol was prescribed in 52 patients; 20 were not reviewed at 48 hrs for a switch to oral route. Of these, only 3 were appropriate prolonged IV prescriptions.Conclusion Audit findings showed inadequate compliance with local prescribing guidelines posing a risk of inappropriately high doses of paracetamol being prescribed to overweight and obese children. In addition, unnecessarily prolonged IV use was observed. Following feedback local guidelines were amended in 2015 to recommend that in obese children, dosing should reflect lean body mass and ideal weight for height. The maximum daily dose was also reduced to 75 mg/kg/day. Prescribers require education regarding this important issue.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Infants and Children